Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
The far-right column shows the total expenditures for each year, starting at only $188.3 million in 2012 and skyrocketing to $13.91 billion by 2022, an increase of an unbelievable 7,921 percent
This combination helps curb hunger effectively
Ann Rheum Dis (2004) 63(2):1706
BPC-157 is not FDA-approved for human use and requires a prescription from a licensed provider to be dispensed from a US compounding pharmacy
eligible Medicare patients can access FDA-approved GLP-1 medications for $50/month through the CMS Medicare GLP-1 Bridge Program - a different pathway worth evaluating before enrolling in a cash-pay compounded program FDA adverse event data (as of May 21, 2026): FDA had received more than 1,700 adverse events associated with compounded semaglutide and tirzepatide combined - a safety signal not specific to Omzo but material context for any compounded GLP-1 enrollment decision
Cao Y, Sun H, Zhu H, et al
US$ 25.40
US$ 27.54
US$ 24.73
US$ 26.60
US$ 25.01
US$ 20.72
US$ 26.16
US$ 29.56
US$ 21.48
US$ 24.95
US$ 27.94
US$ 26.67
US$ 29.83
US$ 23.29
